All Stories

  1. Hepatocellular carcinoma: recent advances and emerging medical therapies

    Article • F1000Research, June 2020, Faculty of 1000, Ltd.

    Lung-Yi Mak, Man-Fung Yuen

  2. Novel developments of hepatitis B: treatment goals, agents and monitoring tools

    Article • Expert Review of Clinical Pharmacology, January 2019, Taylor & Francis

    Lung-Yi Mak, Man-Fung Yuen

  3. Letter: serum HBcrAg is a useful marker for disease monitoring, predicting treatment response and disease outcome of chronic hepatitis B virus infection-authors' reply

    Article • Alimentary Pharmacology & Therapeutics, June 2018, Wiley

    Man-Fung Yuen

  4. An update on the toxicological considerations for protease inhibitors used for hepatitis C infection

    Article • Expert Opinion on Drug Metabolism & Toxicology, May 2018, Taylor & Francis

    Lung-Yi Mak, Man-Fung Yuen

  5. The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C

    Article • Liver International, January 2018, Wiley

    Prof Henry LY Chan, Man-Fung Yuen

  6. Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B

    Article • Alimentary Pharmacology & Therapeutics, January 2018, Wiley

    Prof Henry LY Chan, Man-Fung Yuen

  7. Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of ‘golden window’: A prospective study

    Article • Journal of Gastroenterology and Hepatology, November 2017, Wiley

    Professor Deepak Amarapurkar, Man-Fung Yuen

  8. Hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection

    Article • Alimentary Pharmacology & Therapeutics, October 2017, Wiley

    Man-Fung Yuen

  9. Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study

    Article • Journal of Viral Hepatitis, August 2017, Wiley

    Man-Fung Yuen

  10. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study

    Article • Hepatology, March 2017, Wiley

    Man-Fung Yuen

  11. The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection

    Article • Liver International, February 2017, Wiley

    Man-Fung Yuen

  12. Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA

    Article • Liver International, January 2017, Wiley

    Man-Fung Yuen

  13. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia

    Article • Alimentary Pharmacology & Therapeutics, January 2017, Wiley

    Man-Fung Yuen

  14. Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma

    Article • Journal of Gastroenterology and Hepatology, September 2016, Wiley

    Man-Fung Yuen

  15. High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census

    Article • Liver International, July 2014, Wiley

    Man-Fung Yuen

  16. Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study

    Article • Liver International, June 2014, Wiley

    Man-Fung Yuen

  17. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment

    Article • Journal of Gastroenterology and Hepatology, February 2014, Wiley

    Man-Fung Yuen

  18. A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance

    Article • Hepatology, July 2012, Wolters Kluwer Health

    Man-Fung Yuen

  19. Helicobacter pylori induces promoter methylation of E‐cadherin via interleukin‐1β activation of nitric oxide production in gastric cancer cells

    Article • Cancer, March 2012, Wiley

    Man-Fung Yuen